Sorry, you need to enable JavaScript to visit this website.
Search
March 11, 2022

CDC-Abt Study Shows Pfizer Vaccine Is Moderately Effective for Children

Body

More than 300 news organizations, including CBS and Forbes, quoted Abt’s Lauren Olsho explaining the benefits of our PROTECT study for the CDC, which gathers and tests nasal swabs weekly from children, regardless of whether they had COVID-19 symptoms. “Without regular weekly testing you will miss many infections, particularly for kids, who often have mild symptoms,” said Olsho, the study’s principal investigator. Other pediatric vaccine studies captured only symptomatic cases, and with more home testing, studies like Abt’s are needed for a comprehensive view of vaccine effectiveness, she noted.

Read More

COVID-19 in North America

AcademyHealth 2025 Annual Research Meeting (ARM)

Join Abt Global at AcademyHealth’s 2025 Annual Research Meeting (ARM) in Minneapolis.

Learn More
Event

AI Enabled Code Conversion for Legacy System Modernization

Abt uses AI-enabled code conversion to help federal agencies modernize legacy systems securely, efficiently, and at scale.

Learn More
Spotlight On

Feeding the Nation: How Innovation Fuels American Agriculture

America’s farmers feed our families and care for the land, whether they manage a few acres or thousands. Across the country, amid shrinking margins, producers face challenges in accessing loans, responding to disasters, and navigating federal assistance. USDA’s partnership with Abt Digital Solutions is making it easier for them to stay productive and steward America’s land.

Learn More
Impact Brief

Wyoming’s Plan to Promote Housing and Economic Development

Abt developed a strategic housing action plan, story map, and tool that will help Wyoming implement solutions for its housing affordability challenges.

Learn More
Blog